Overall, this study confirms heterozygous variants in ATP5F1A and ATP5F1B as an underreported cause of a wider range of neurological phenotypes with prominent movement disorders and permits the determination of an expanded mutational spectrum. This evidence concerns the gene ATP5F1B and movement disorder.